Michael J. Fox Foundation for Parkinson's Research

2016 · research · Target Advancement Program

Validation of Cyclin-G Associated kinase (GAK) as a Target for Parkinson's Disease

Marie-Christine Chartier-Harlin · Umr-s1172, Jean-pierre Aubert Research Center (inserm - Lille University - Lille University Hospital

2016 · research · Therapeutic Pipeline Program

Long-term Cell Restorative Treatment for Parkinson’s Disease

Ole Isacson · Harvard University

2016 · research · Research Grant

Chronic Effects of Low Frequency Deep Brain Stimulation on Aspiration, Freezing of Gait and Other Axial and Motor Symptoms in Parkinson's Disease

Tao Xie · University of Chicago Medical Center

2016 · research · Target Advancement Program

Alpha-Synuclein Aggregates as an Inducer of Glial Senescence: Potential Role in Parkinson's Disease

Julie K. Andersen · Buck Institute for Research on Aging

2016 · research · Research Grant

Defining Structural Forms of Alpha-synuclein Responsible for Key Features Associated with Parkinson's Disease

Nunilo Cremades · Universidad de Zaragoza

2016 · research · Research Grant

Parkinson's Disease Genetics Sequencing Consortium

Michael A. Nalls · Laboratory Of Neurogenetics, Intramural Research Program, National Institute On Aging

2016 · research · Research Grant

Immune and Bioenergetic Effects of Alpha-synuclein Preformed Fibril Seeding

Richard Jay Smeyne · Thomas Jefferson University

2016 · research · Target Advancement Program

Neuroprotective Effects of Endosulfine-alpha in PD

Erwan Bezard · Institute Of Neurodegenerative Diseases, Cnrs Umr 5293, University Victor Segalen

2016 · research · Target Advancement Program

GADD34 Inhibition as a Neuroprotective Strategy in Parkinson's Disease

Oren A. Levy · Columbia University Irving Medical Center

2016 · research · Target Advancement Program

The Role of LRRK2 in Neuronal Calcium Maintenance

Ole Isacson · Harvard University

2016 · research · Research Grant

LRRK2 Non-coding Variation in Parkinson's Disease

Owen Anthony Ross · Mayo Clinic in Florida

2016 · research · Target Advancement Program

Farnesoid X Receptor as a Target to Reduce Meuroinflammation

Jason R. Richardson · Northeast Ohio Medical University

2016 · research · Research Grant

LRRK2 Function in Immunity

Malú G. Tansey · University of Florida

2016 · research · Research Grant

Therapeutic Effects of XPro1595 on Motor and Non-motor Outcomes in a Pre-clinical Model of Parkinson's disease

Raymond Joseph Tesi · Inmune Bio

2016 · research · Research Grant

Effect of Parkin on Mitochondrial Protein Expression

Howard Steven Fox · University of Nebraska Medical Center

2016 · research · Research Grant

GBA Meta-analysis Initiative: Charting a Path to Success for Clinical Trials in Patients with GBA-PD

Bing Huang Wang · Sanofi (France)

2016 · research · Research Grant

Investigative Safety Study in LRRK2 Pre-clinical Models

Pascale Brunel · Sanofi (France)

2016 · research · Therapeutic Pipeline Program

USP13 Regulation of Parkin Stability

Charbel Moussa · Georgetown University

2016 · research · Target Advancement Program

Targeting the Transcriptional Regulator of Autophagy LMX1B for Parkinson's Disease Therapeutic Development

Ariadna Laguna-Tuset · Fundacio Hospital Universitari Vall D'hebron - Institut De Recerca

2016 · research · Target Advancement Program

Targeting the Cell's Energy System in Parkinson's Disease

Jeremy W. Chambers · Florida International University

2016 · research · Research Grant

SudoScan as a Biomarker of Parkinson's Disease

Ronald B. Postuma · Research Institute of the McGill University Health Centre

2016 · research · Biomarkers Across Neurodegenerative Diseases

Homo- and Hetero-aggregates as Biomarkers in Neurodegenerative Disorders

Dieter Willbold · Forschungszentrum Jülich

2016 · research · Therapeutic Pipeline Program

Blocking Inflammasome-induced Neuroinflammation in Parkinson's Disease with a Potent, Orally Available Small Molecule

Matthew Allister Cooper · Inflazome Ltd

2016 · research · Research Grant

Tau Imaging in Parkinson's Disease

Joel Kramer · University of California, San Francisco

2016 · research · Access to Data and Biospecimens

Evaluation of Glucocerebrosidase Pathway Biomarkers in Parkinson's Disease

2016 · research · Research Grant

Analysis of Parkin Activity in Pre-clinical Models of Parkinson's

Matthew S. Goldberg · University of Alabama at Birmingham

2016 · research · Research Grant

Impact of LRRK2 Kinase Activity on Synaptic Vesicle Trafficking

Giovanni Piccoli · Vita-Salute San Raffaele University

2016 · research · Target Advancement Program

High-throughput LRRK2 Ubiquitination Assay

R. Jeremy Nichols · Stanford University

2016 · research · Target Advancement Program

Targeting Novel Transcriptional Pathways to Reduce Alpha-synuclein Expression

Miquel Vila · Catalan Institution For Research And Advanced Studies, Vall D’hebron Research Institute

2016 · research · Research Grant

Validation of Uncharacterized LRRK2 Phosphorylation Sites

R. Jeremy Nichols · Stanford University

2016 · research · Therapeutic Pipeline Program

Rehabilitation Treatment for Airway Protection in Parkinson's Disease

Michelle S. Troche · Columbia University

2016 · research · Improved Biomarkers and Clinical Outcome Measures

Defining a Parkinson's Disease-specific Breath Fingerprint of Inflammatory and Neurodegenerative Processes

Malú G. Tansey · University of Florida

2016 · research · Research Grant

Rab Detection Initiative

R. Jeremy Nichols · Stanford University

2016 · research · Improved Biomarkers and Clinical Outcome Measures

Corneal Confocal Microscopy: A Novel Imaging Biomarker for Parkinson's Disease

Monty Silverdale · Salford Royal NHS Foundation Trust

2016 · research · Target Advancement Program

Alpha-synuclein Toxicity in LRRK2 Pre-clinical Models and Rescue by LRRK2 Silencing

Austen James Milnerwood · University of British Columbia

2016 · research · Access to Data and Biospecimens

Single Molecule Detection of Oligomers in Cerebrospinal Fluid

Nicholas William Wood · UCL Queen Square Institute of Neurology

2016 · research · Research Grant

Combining Mass Spectrometry with Genetic and Pharmacological Approaches to Discover and Validate LRRK2 Substrates

Jarrod A. Marto · Brigham and Women's Hospital

2016 · research · Target Advancement Program

LRRK2 Mutations and the Development of Therapeutic LRRK2 Inhibitors

Nicolas Dzamko · The University of Sydney

2016 · research · Improved Biomarkers and Clinical Outcome Measures

Identification of Tear Biomarkers for Individuals with Parkinson's Disease

Sarah F. Hamm-Alvarez · University of Southern California

2016 · research · Therapeutic Pipeline Program

KH176 as a Novel Disease-modifying Therapeutic for Parkinson’s Disease

Johannes Albertus Maria Smeitink · Radboud University Medical Center